American Homecare Federation Receives Top Satisfaction Rating
ENFIELD, Connecticut – June 24, 2015 – The American Homecare Federation (AHF) announces its 2015 patient satisfaction survey results.
American Homecare Federation, a Diplomat Pharmacy, Inc. company (NYSE: DPLO), announced its 2015 satisfaction survey results, receiving a 100 percent patient satisfaction rating for over 10 years in a row. Headquartered in Enfield, Connecticut, AHF is a specialty pharmacy that provides homecare pharmacy services to patients living with hemophilia, von Willebrand disease and other bleeding disorders.
AHF has always taken great pride in the quality of services provided to the hemophilia community by providing assistance to patients in overcoming the medical, economic and societal barriers often faced by those living with hemophilia and other bleeding disorders.
“Our families have always been our No. 1 priority here at AHF,” said Mark Zatyrka, Director of Marketing at AHF. “I am so proud of the amazing team we have here at AHF. We will never stop fighting for whatever is best for our patients.”
AHF was founded in 1989 by Donald Colburn and his wife, Kathy Keenan, who sought a solution to make home treatment of bleeding disorders easier to manage. The couple saw a need for a comprehensive, well-managed approach to treatment to ease the burden for families facing the same challenges. Since then, AHF has established itself as a leader in the bleeding disorders community, developing disease management programs for individuals and families that have significantly impacted and shaped the modern approach to patient care for these conditions.
The company takes pride in not only providing the best possible care for their patients, but in supporting the bleeding disorders community as a whole. AHF provides significant annual donations to the Hemophilia Federation of America as well as many local and regional bleeding disorder organizations and foundations. Additional support is extended through scholarships, summer camp programs and volunteer hours from AHF staff members.
To learn more about the services AHF provides, please visit www.AHFinfo.com or call 800.243.4621.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management’s good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat’s filings with the Securities and Exchange Commission, including “Risk Factors” in Diplomat’s Annual Report on Form 10-K for the year ended December 31, 2014 and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.
Kali Lucas, Public Relations Coordinator
810.768.9580 | email@example.com
@PharmacDailyRT @PharmacDaily: @DiplomatRx to distribute Puma Biotechnology’s new cancer drug $DPLO https://t.co/gl0v6WURVV4 days ago
@DiplomatRxNerlynx (neratinib) tablets for HER2+ Breast Cancer in the Extended Adjuvant Setting https://t.co/vi3ACWhbfe5 days ago
@AJPB_JournalRT @AJPB_Journal: Be sure to check out our Insights page featuring videos of Cheryl Allen from @DiplomatRx discussing #RA https://t.co/qxZc…2 weeks ago
@DiplomatRxWe're with @340BCoalition this week in Washington D.C.! Come say hello.2 weeks ago
@SpecialtyPTimesRT @SpecialtyPTimes: Rheumatoid Arthritis Treatment Guidelines https://t.co/sEhe74UozC #rheumatoidarthritis @DiplomatRx3 weeks ago